Wenjun Cheng

Academic / Other · 1 registered clinical trial.

Status	Trial	Phase	Started
Active Not Recruiting	Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cance Ovarian Neoplasms, Fallopian Tube Neoplasms, Neoplasms by Site	Phase 2	2021-08-24